About: Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Background. The goal of this review is to summarize the results of head to head efficacy studies that compare second generation antipsychotics in the treatment of schizophrenia and related disorders. Methods. A literature search through the Medline database and Google was conducted. Articles published up to September 2005 were included. Abstracts from conference papers and posters were not included. Results. Randomized controlled trial data on possible differences in efficacy among atypical antipsychotics are limited. Moreover, the comparison is difficult, as studies differ in outcome measures. The results indicate that first-line second-generation antipsychotics (amisulpride, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone and zotepine) show comparable efficacy. Conclusion. Possible new studies should focus on long-term effects, including cost-effectiveness, quality of life, social functioning and service utilization.
  • Background. The goal of this review is to summarize the results of head to head efficacy studies that compare second generation antipsychotics in the treatment of schizophrenia and related disorders. Methods. A literature search through the Medline database and Google was conducted. Articles published up to September 2005 were included. Abstracts from conference papers and posters were not included. Results. Randomized controlled trial data on possible differences in efficacy among atypical antipsychotics are limited. Moreover, the comparison is difficult, as studies differ in outcome measures. The results indicate that first-line second-generation antipsychotics (amisulpride, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone and zotepine) show comparable efficacy. Conclusion. Possible new studies should focus on long-term effects, including cost-effectiveness, quality of life, social functioning and service utilization. (en)
  • Cílem článku je provést přehled všech studií, které porovnávaly účinnost antipsychotik druhé generace mezi sebou. Randomizovaných studií je nedostatek, vzájemná porovnání jsou obtížná, jelikož se studie liší sledovanými proměnnými. Na základě dostupných dat vychází, že antipsychotika druhé generace mají srovnatelnou účinnost. (cs)
Title
  • Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?
  • Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders? (en)
  • Liší se mezi sebou v účinnosti antipsychotika druhé generace v léčbě onemocnění schizofrenního okruhu? (cs)
skos:prefLabel
  • Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?
  • Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders? (en)
  • Liší se mezi sebou v účinnosti antipsychotika druhé generace v léčbě onemocnění schizofrenního okruhu? (cs)
skos:notation
  • RIV/00216208:11120/07:00000339!RIV08-MSM-11120___
http://linked.open.../vavai/riv/strany
  • 133-143
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(1M0517)
http://linked.open...iv/cisloPeriodika
  • 2
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 410716
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11120/07:00000339
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • atypical antipsychotics; schizophrenia; efficacy (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [770B6C179FB4]
http://linked.open...i/riv/nazevZdroje
  • Annals of Clinical Psychiatry
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 19
http://linked.open...iv/tvurceVysledku
  • Höschl, Cyril
  • Španiel, Filip
  • Motlová, Lucie
  • Balon, Richard
issn
  • 1040-1237
number of pages
http://localhost/t...ganizacniJednotka
  • 11120
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software